Published May 23, 2018 | Version version1
Other Open

Supporting material for:Optimising the design of a pre-clinical patient-derived tumor xenograft mouse population study to better predict clinical trial drug response

  • 1. Bioscience, Oncology, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Cambridge, UK
  • 2. Quantitative Biology, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Cambridge, UK

Description

Supporting material, enabling a reproducible analysis, for the manuscript "Optimising the design of a pre-clinical patient-derived tumor xenograft mouse population study to better predict clinical trial drug response ".

Files

README.txt

Files (1.7 MB)

Name Size Download all
md5:1aa529c02bb09b343be9d280712ab52c
199.2 kB Download
md5:b1adc7943f4358836db7f37c33c60c76
1.5 MB Download
md5:ac130cd91519567f27e55da25c6a5ff0
277 Bytes Preview Download